Journal profile · Multiple
Journal of Behavior Therapy and Experimental Psychiatry
ISSN 0005-7916 · eISSN 1873-7943 · Elsevier
Journal of Behavior Therapy and Experimental Psychiatry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.27; hybrid open access; APC about USD 3,140; median 214 days to acceptance (82 articles, last 24 months); 50 articles in 2025; indexed in SSCI and Scopus.
Scope
Aims, scope and focus
Journal of Behavior Therapy and Experimental Psychiatry is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Behavioral and Psychological Studies and Child and Adolescent Psychosocial and Emotional Development, together about 37.2% of its articles. Its main subfields are Clinical Psychology. (generated from OpenAlex topic counts and CAS ranking data)
A Journal of Experimental PsychopathologyThe Journal welcomes contributions to the understanding and treatment of psychopathology. Such contributions may stem from various theoretical perspectives. The Journal primarily focuses on (quasi)experimental tests of psychological approaches to psychopathology, though contributions from medicine, biology, sociology, or epidemiology may be considered. The same holds for non-experimental approaches (e.g., prospective approaches), which may occasionally be published if deemed relevant for the field of experimental psychopathology. Papers to be published generally focus on:Theoretically or clinically relevant differences between specific patient groups and other groups, if experimentally tested;(Transdiagnostic) mechanisms that cause, perpetuate or reduce disorders;Diagnostic or therapeutic proceduresParticipants in the studies may be patients, healthy subjects, or animals, depending on the relevance of the subject characteristics for the question to be answered. We encourage the investigation of transdiagnostic constructs. Relatedly, we strongly encourage studies testing hypotheses on characteristics of a disorder to not only include a non-patient control group, but also at least one appropriate clinical control group, to assess the specificity of the effect. We cannot guarantee acceptance of studies missing an appropriate clinical control group.Pre-registration of all studies is strongly encouraged and justification of statistical power required. We ask authors who submit studies that were not pre-registered to provide a motivated justification in their cover letter. Clinical trials (RCTs and others) should be registered in an official trial register and the registration number should be reported. These studies should include a flow diagram according to the most recent CONSORT guidelines and a CONSORT checklist should accompany the submission. See http://www.consort-statement.org for the guidelines and forms. Any changes in the submitted study as compared to the pre-registered study (e.g., intended sample size, primary and secondary outcome variables, method) should be stated explicitly in the manuscript.Case studies, open trials, and pilot studies may be considered for publication in the Journal if they are unusually innovative Consecutive case series with appropriate designs (i.e., contrasting at least two conditions; e.g. multiple baseline design) and appropriate statistical analyses are considered for publication.Theoretical contributions on topics relevant to the field of experimental psychopathology are also considered as well as systematic reviews and meta-analyses, given that they meet the appropriate guidelines for reporting. Replications are essential in science and are, to the present editors' opinion, often undervalued. Short reports of attempts to replicate experimental studies, whether successful or failed, and whether applied or fundamental, are considered for publication, if appropriately powered. The maximum number of words is 2500 for these reports.All submissions will first be screened on the degree to which they match the Aims and Scope of the Journal.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Gideon AnholtPublisher website
Editorial board by country: none in mainland China; most named United States 14, Netherlands 13, Germany 11, Canada 8, United Kingdom 7 (62 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology16%
- Behavioral and Psychological StudiesPsychology10.9%
- Child and Adolescent Psychosocial and Emotional DevelopmentPsychology10.4%
- Obsessive-Compulsive Spectrum DisordersPsychology6.4%
- Psychotherapy Techniques and ApplicationsPsychology4.9%
- Autism Spectrum Disorder ResearchNeuroscience4.6%
- Personality Disorders and PsychopathologyPsychology3.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Psychiatry | Zone 4 |
| Minor | Psychology, Clinical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychology, Clinical | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Psychiatry | Zone 4 |
| Minor | Psychology, Clinical | Zone 4 |
Top journal: noReview journal: no
Database indexing
SSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.27LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 4.3Publisher website ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 141OpenAlex ·
- i10-index
- 2,218OpenAlex ·
- 2-year mean citedness
- 1.31OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 45.73%LetPub ·
Volume
- Articles per year
- 45LetPub ·
Articles by year OpenAlex count · 4,129 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 23 | 3 |
| 2025 | 50 | 32 | 73 |
| 2024 | 44 | 33 | 96 |
| 2023 | 81 | 44 | 676 |
| 2022 | 72 | 30 | 694 |
| 2021 | 60 | 26 | 535 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
214 daysMedian, submission to acceptance · P25–P75 149 days – 323 days
- Acceptance to online
- median 5 days (81 articles)
- Submission to online
- median 233 days
- Sample
- 82 articles with submission and acceptance dates (104 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 89 daysPublisher website ·
- Submission to acceptance
- 224 daysPublisher website ·
- Acceptance to publication
- 7 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,140 / EUR 2,940 / GBP 2,510 / JPY 389,450 | — | — | |
| Publisher website | USD 3,610 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 5,500 words
- Reference style
- APA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted4, with length limits
- regular manuscriptsRegular manuscripts should not exceed 5500 words (15-20 pages) of body text.Length not stated
- reviewRegular manuscripts should not exceed 5500 words (15-20 pages) of body text. Short reports should have a maximum of 3000 words. Reviews should not exceed 9,000 …main text ≤ 9,000 words
- reviewsReviews should not exceed 9,000 words.Length not stated
- short reportsShort reports should have a maximum of 3000 words.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Pre-registration strongly encouraged Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 0005-7916
- Electronic ISSN
- 1873-7943
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Behavior Therapy and Experimental Psychiatry
What CAS zone is Journal of Behavior Therapy and Experimental Psychiatry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Behavior Therapy and Experimental Psychiatry is in Zone 4 of Medicine, and in Zone 4 of the minor category Psychiatry / Psychology, Clinical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Behavior Therapy and Experimental Psychiatry?
The latest impact factor listed by LetPub is 2.27; CiteScore 4.3, h-index 141.
How long does peer review take at Journal of Behavior Therapy and Experimental Psychiatry?
Based on the dates recorded on 82 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 214 days (interquartile range 149–323 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Behavior Therapy and Experimental Psychiatry?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 5,500 words; Reference style: APA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Behavior Therapy and Experimental Psychiatry based?
Of the 62 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (14), Netherlands (13) and Germany (11). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Behavior Therapy and Experimental Psychiatry?
According to LetPub and DOAJ records, Journal of Behavior Therapy and Experimental Psychiatry is indexed in SSCI and Scopus.
Is Journal of Behavior Therapy and Experimental Psychiatry open access, and what is the APC?
Journal of Behavior Therapy and Experimental Psychiatry is a hybrid journal. For open-access publication: APC about USD 3,140.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .